Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD). The study suggests that the anti-inflammatory and anti-oxidative effects of metformin can protect against AMD while it controls diabetes. The research will be presented today at AAO 2018, the 122nd Annual Meeting of the American Academy of Ophthalmology.
For more information: https://www.aao.org/newsroom/news-releases/detail/diabetes-medication-may-protect-against-common-cau